WASHINGTON — In the final weeks before Tuesday’s midterm elections, the pharmaceutical industry’s campaign donations began flowing heavily and unexpectedly in a new direction: toward Democrats.
The party received a full 63 percent of the industry’s campaign contributions reported in the first half of October, according to data compiled by the Center for Responsive Politics. That’s a new trend to cap off a tumultuous election cycle: Up to this point, just over half of drug industry money has flowed toward Republicans, and the GOP has received substantially more campaign cash from the pharmaceutical and health products industry in the past decade.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
